Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSBR stock hub

Champions Oncology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSBRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

83.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CSBR

In the news

Latest news · CSBR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-47.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-131.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSBR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000771856
Company name	Champions Oncology, Inc.
Country	United States
Country code	US
Cusip	15870P307
Employees	213
Employees Change	3%
Employees Change Percent	1.43
Enterprise value	$81.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1986-03-25
Isin	US15870P3073
Last refreshed	2026-05-10
Market cap	$83.6M
Market cap category	Micro-Cap
Price	$6.02
Price currency	USD
Rev Per Employee	272,042.25x
Sector	Healthcare
Sic	2836
Symbol	CSBR
Website	https://www.championsoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.8%
EV Sales Forward	1.8x
EV/FCF	21.35x
EV/Sales	1.41x
FCF yield	4.56%
P/B ratio	19.52x
P/S ratio	1.44x
PS Forward	1.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.83%
EBITDA Margin	-1.33%
FCF margin	6.59%
Gross margin	45.88%
Gross Profit	$26.6M
Gross Profit Growth	-12.04%
Gross Profit Growth Q	-25.88%
Gross Profit Growth3 Y	1.72%
Gross Profit Growth5 Y	7.43%
Net Income	$-2.3M
Net Income Growth Years	1%
Pretax Margin	-4.14%
Profit Margin	-4.04%
Profit Per Employee	$-11,000
Profitable Years	1
ROA	-4.7
Roa5y	-1.96
ROCE	-28.6
ROE	-47.59
Roe5y	-18.94
ROIC	-131.6
Roic5y	2.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.04%
Cagr15y	-4.8%
Cagr1y	3.62%
Cagr20y	17.48%
Cagr3y	5.2%
Cagr5y	-9.9%
EPS Growth Years	1
FCF Growth3 Y	10.32%
OCF Growth3 Y	-6.98%
OCF Growth5 Y	9.09%
Revenue Growth	-1.1x
Revenue Growth Q	-2.82x
Revenue Growth Years	1x
Revenue Growth3 Y	2.58x
Revenue Growth5 Y	8.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.96
Assets	$28.4M
Cash	$7.1M
Current Assets	$20.2M
Current Liabilities	$20.7M
Debt	$5M
Debt EBITDA	$4.86
Debt Equity	$1.14
Debt FCF	$1.31
Equity	$4.4M
Interest Coverage	-82.3
Liabilities	$24.1M
Long Term Assets	$8.3M
Long Term Liabilities	$3.4M
Net Cash	$2.1M
Net Cash By Market Cap	$2.55
Net Debt Equity	$-0.49
Net Debt FCF	$-0.56
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$0.28
WACC	6.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.98
Net Working Capital	$-6M
Quick ratio	0.93
Working Capital	$-492,000
Working Capital Turnover	$-174

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.64%
1Y total return	3.61%
200-day SMA	6.48
3Y total return	16.44%
50-day SMA	5.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-40.63%
All Time High	33
All Time High Change	-81.76%
All Time High Date	1992-07-24
All Time Low	0.07
All Time Low Change	8,261.11%
All Time Low Date	2003-02-19
ATR	0.26
Beta	0.43
Beta1y	0.21
Beta2y	0.55
Ch YTD	-12.88
High	6.3
High52	9.63
High52 Date	2025-07-09
High52ch	-37.49%
Low	5.84
Low52	5.5
Low52 Date	2026-03-13
Low52ch	9.46%
Ma50ch	1.47%
Price vs 200-day SMA	-7.13%
RSI	52.44
RSI Monthly	47.41
RSI Weekly	45.65
Sharpe ratio	0.32x
Sortino ratio	0.61
Total Return	1.39%
Tr YTD	-12.88
Tr15y	-52.22%
Tr1m	-1.95%
Tr1w	0.5%
Tr3m	-8.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$0.09
Earnings EPS Estimate Growth	-75
Earnings Revenue Estimate	16,613,000x
Earnings Revenue Estimate Growth	-2.5x
Operating Income	$-2.2M
Operating margin	-3.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,188,352%
Float Percent	37.36%
Net Borrowing	-154,000
Shares Insiders	26.5%
Shares Institutions	12%
Shares Out	13,886,826
Shares Qo Q	-3.95%
Shares Yo Y	-1.39%
Short Float	1.58%
Short Ratio	8.57
Short Shares	0.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.8M
Average Volume	7,652.45x
Bv Per Share	0.31
CAPEX	$-578,000
Ch10y	48.64
Ch15y	-52.22
Ch1m	-1.95
Ch1w	0.5
Ch1y	3.61
Ch20y	2,408.3
Ch3m	-8.09
Ch3y	16.44
Ch5y	-40.63
Ch6m	-10.68
Change	0.5%
Change From Open	0.5
Close	5.99
Days Gap	0
Depreciation Amortization	1,450,000
Dollar Volume	124,355.1
Earnings Date	2026-03-12
Earnings Time	amc
EBIT	$-2.2M
EBITDA	$-772,000
EPS	$-0.17
F Score	2
FCF	$3.8M
FCF EV Yield	4.68x
FCF Per Share	$0.27
Financing CF	86,000
Fiscal Year End	April
Founded	1,985
Goodwill	335,000
Income Tax	$-55,000
Investing CF	-555,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2026-01-31
Last Split Date	2015-08-12
Last Split Type	Reverse
Last10k Filing Date	2025-07-23
Ma150	6.41
Ma150ch	-6.05%
Ma20	5.96
Ma20ch	1.04%
Net CF	3,925,000
Next Earnings Date	2026-07-22
Open	5.99
Optionable	Yes
P FCF Ratio	21.91
P OCF Ratio	19.03
Position In Range	39.13
Post Close	6.02
Postmarket Change Percent	0.33
Postmarket Price	$6.04
Ppne	7,731,000
Price Date	2026-05-08
Ptbv Ratio	21.17
Relative Volume	2.7x
Revenue	57,945,000x
SBC By Revenue	1.74x
Share Based Comp	1,011,000
Tax By Revenue	-0.09x
Tr20y	2,408.33%
Tr6m	-10.68%
Us State	New Jersey
Volume	20,657
Z Score	0.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSBR pay a dividend?

Capital-return profile for this ticker.

Performance

CSBR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSBR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.0%

Float: +37.4% of shares outstanding

Insider ownership

+26.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CSBR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.4

Neutral momentum band

Price vs 200-day MA

-7.1%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSBR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CSBR stock rating?

Champions Oncology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CSBR analysis?

The full report lives at /stocks/CSBR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CSBR?

The latest report frames CSBR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CSBR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.